James Loerop

Filings by James Loerop span 2 companies, the busiest being Aclaris Therapeutics, Inc. and Anika Therapeutics, Inc. In total, 32 filings cover trades dated from 8 July 2020 to 3 February 2026.

Both buying and selling appear: 1 purchase worth €92k, against 2 sales worth €94k. Sales outweigh purchases by €1,643. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 13 share grants and 16 option exercises.

The record was last updated on 5 February 2026 with an option exercise in Aclaris Therapeutics, Inc. The last purchase on record was published on 28 August 2023, which is 1,152 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.